Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii
出版年份 2015 全文链接
标题
Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii
作者
关键词
-
出版物
JOURNAL OF ANTIBIOTICS
Volume 69, Issue 6, Pages 415-421
出版商
Springer Nature
发表日期
2015-12-16
DOI
10.1038/ja.2015.127
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
- (2015) Roger L Nation et al. LANCET INFECTIOUS DISEASES
- Bactericidal Activity, Absence of Serum Effect, and Time-Kill Kinetics of Ceftazidime-Avibactam against β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
- (2014) Tiffany R. Keepers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Rate-Area-Shape Modeling Approach To Quantify Bacterial Killing and Regrowth forIn VitroStatic Time-Kill Studies
- (2014) Soon-Ee Cheah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus
- (2014) Rajmohan Rajamuthiah et al. PLoS One
- Polymyxin use as a risk factor for colonization or infection with polymyxin-resistantAcinetobacter baumanniiafter liver transplantation
- (2014) M.P. Freire et al. Transplant Infectious Disease
- Overcoming the current deadlock in antibiotic research
- (2014) Till F. Schäberle et al. TRENDS IN MICROBIOLOGY
- Unique Structural Modifications Are Present in the Lipopolysaccharide from Colistin-Resistant Strains of Acinetobacter baumannii
- (2013) Mark R. Pelletier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
- (2013) H. W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics
- (2013) Tony Velkov et al. Future Microbiology
- Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae
- (2013) Tony Velkov et al. Innate Immunity
- Antibiotics in the clinical pipeline in 2013
- (2013) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Rapid Killing of Acinetobacter baumannii by Polymyxins Is Mediated by a Hydroxyl Radical Death Pathway
- (2012) Timothy R. Sampson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis
- (2012) A. M. Sandri et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
- (2012) Y. Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula
- (2011) Phillip J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis Patients
- (2011) Samuel M. Moskowitz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- In vitro efficiency of the piperacillin/tazobactam combination against inhibitor-resistant TEM- and complex mutant TEM-producing clinical strains of Escherichia coli
- (2011) Frédéric Robin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
- (2011) Linda Ejim et al. Nature Chemical Biology
- Polymyxin-Resistant Clinical Isolates ofEscherichiacoli
- (2010) Carl Urban et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emerging Resistant Gram-Negative Aerobic Bacilli in Hospital-Acquired Infections
- (2010) Anjali N. Kunz et al. CHEMOTHERAPY
- fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
- (2010) R. V. Dudhani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Repositioning of an existing drug for the neglected tropical disease Onchocerciasis
- (2010) Christian Gloeckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
- (2009) Jean-Louis Vincent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Structure−Activity Relationships of Polymyxin Antibiotics
- (2009) Tony Velkov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
- (2008) A. Poudyal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ivermectin: 25 years and still going strong
- (2007) S. Õmura INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More